Lifitegrast: a novel drug for patients with dry eye disease

The objective of this article is to review the pharmacology, efficacy, and safety of lifitegrast and determine its role relative to other agents in the management of dry eye disease. A PubMed search (1946 to December 2018) using the terms lifitegrast and SAR 1118 was conducted to identify relevant a...

Descripción completa

Detalles Bibliográficos
Autores principales: Haber, Stacy L., Benson, Vera, Buckway, Casey J., Gonzales, Jennifer M., Romanet, David, Scholes, Brittany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710705/
https://www.ncbi.nlm.nih.gov/pubmed/31489402
http://dx.doi.org/10.1177/2515841419870366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710705/
https://www.ncbi.nlm.nih.gov/pubmed/31489402
http://dx.doi.org/10.1177/2515841419870366

Ejemplares similares